Preventing mother-to-child transmission of HIV - Protecting this generation and the next

New England Journal of Medicine

Volumn 363, Issue 16, 2010, Pages 1570-1572

  Lallemant, Marc ^a   Jourdain, Gonzague ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LOPINAVIR; NEVIRAPINE; RITONAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT;

ANTIVIRAL RESISTANCE; DRUG EXPOSURE; EDITORIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT FAILURE; TREATMENT RESPONSE; VIRUS MUTATION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION; FEMALE; HIV INFECTIONS; HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; TRANSMISSION; VERTICAL TRANSMISSION;

ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; NEVIRAPINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 77957936630     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1009863     Document Type: Editorial

References (10)

1. AIDS epidemic update: November 2009. Geneva: World Health Organization, United Nations Programme on HIV/AIDS. (http://data.unaids.org/pub/Report/2009/ JC1700-Epi-Update-2009-en.pdf.)
2. Mofenson LM. Protecting the next generation - eliminating perinatal HIV-1 infection. N Engl J Med 2010;362:2316-8.
3. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
4. Lockman S, Hughes MD, McIntyre J, et al. Antiretroviral therapies in women after single-dose nevirapine exposure. N Engl J Med 2010;363:1499-509.
5. Palumbo P, Lindsey J, Hughes MD, et al. Antiretroviral treatment for children with peripartum nevirapine exposure. N Engl J Med 2010;363:1510-20.
6. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach. Geneva: World Health Organization, 2010.
7. Coovadia A, Abrams EJ, Stehlau R, et al. Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial. JAMA 2010;304:1082-90.
8. McIntyre JA, Hopley M, Moodley D, et al. Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial. PLoS Med 2009;6(10):e1000172.
9. Lallemant M, Ngo-Giang-Huong N, Jourdain G, et al. Efficacy and safety of one-month postpartum zidovudine and didanosine to prevent HIV-resistance mutations following intrapartum single-dose nevirapine. Clin Infect Dis 2010;50:898-908.
10. PMTCT Strategic Vision 2010-2015. Preventing mother-to-child transmission of HIV to reach the UNGASS and Millennium Development goals: moving towards the elimination of paediatric HIV. Geneva: World Health Organization, 2010. (http://www.who.int/hiv/pub/mtct/strategic-vision.pdf.)